Gastroenterology
Volume 136, Issue 1 , Pages 99-107 , January 2009

Clinical Staging and Survival in Refractory Celiac Disease: A Single Center Experience

  • Alberto Rubio–Tapia

      Affiliations

    • Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Darlene G. Kelly

      Affiliations

    • Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Brian D. Lahr

      Affiliations

    • Division of Biomedical Statistic and Informatics, Department of Health Science Research, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Ahmet Dogan

      Affiliations

    • Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Tsung–Teh Wu

      Affiliations

    • Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Joseph A. Murray

      Affiliations

    • Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN
    • Corresponding Author InformationAddress requests for reprints to: Joseph A. Murray, MD, 200 First Street SW, Rochester, MN 55905, USA. fax: (507) 266-9081

Received 1 July 2008 ,Accepted 2 October 2008.

References 

  1. Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731–1743
  2. Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol. 2002;97:2016–2021
  3. Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007;5:445–450
  4. Trier JS. Celiac sprue. N Engl J Med. 1991;325:1709–1719
  5. Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology. 2000;119:243–251
  6. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma (French Coeliac Disease Study Group). Lancet. 2000;356:203–208
  7. Patey-Mariaud De Serre N, Cellier C, Jabri B, et al. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology. 2000;37:70–77
  8. Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology. 1998;114:471–481
  9. Hamilton JD, Chambers RA, Wynn-Williams A. Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease. Lancet. 1976;1:1213–1216
  10. Maurino E, Niveloni S, Chernavsky A, et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol. 2002;97:2595–2602
  11. Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut. 2007;56:1373–1378
  12. Brar P, Lee S, Lewis S, Egbuna I, Bhagat G, Green PH. Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol. 2007;102:2265–2269
  13. Cellier C, Cerf-Bensussan N. Treatment of clonal refractory celiac disease or cryptic intraepithelial lymphoma: A long road from bench to bedside. Clin Gastroenterol Hepatol. 2006;4:1320–1321
  14. Al-toma A, Verbeek WH, Mulder CJ. The management of complicated celiac disease. Dig Dis. 2007;25:230–236
  15. Al-toma A, Visser OJ, van Roessel HM, et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood. 2007;109:2243–2249
  16. Maurino E, Niveloni S, Chernavsky AC, et al. Clinical characteristics and long-term outcome of patients with refractory sprue diagnosed at a single institution. Acta Gastroenterol Latinoam. 2006;36:10–22
  17. Biagi F, Corazza GR. Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol. 2001;13:561–565
  18. Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: Clinical features and treatment of 31 patients in a single center. J Clin Oncol. 2000;18:795–803
  19. Robert ME, Ament ME, Weinstein WM. The histologic spectrum and clinical outcome of refractory and unclassified sprue. Am J Surg Pathol. 2000;24:676–687
  20. Akram S, Murray JA, Pardi DS, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol. 2007;5:1282–1290quiz 1245
  21. Marsh MN. Gluten, major histocompatibility complex, and the small intestine (A molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”)). Gastroenterology. 1992;102:330–354
  22. Al-Toma A, Goerres MS, Meijer JW, et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol. 2006;4:1322–1327quiz 1300
  23. Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PG. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol. 1997;151:493–498
  24. Midhagen G, Aberg AK, Olcen P, et al. Antibody levels in adult patients with coeliac disease during gluten-free diet: A rapid initial decrease of clinical importance. J Intern Med. 2004;256:519–524
  25. Ientile R, Caccamo D, Griffin M. Tissue transglutaminase and the stress response. Amino Acids. 2007;33:385–394
  26. Goerres MS, Meijer JW, Wahab PJ, et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther. 2003;18:487–494
  27. Verbeek WH, Goerres MS, von Blomberg BM, et al. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease. Clin Immunol. 2008;126:48–56
  28. Al-Toma A, Verbeek WH, Visser OJ, et al. Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Dig Liver Dis. 2007;39:634–641

 The authors disclose the following: Supported by the National Institutes of Health (NIH) under Ruth L. Kirschstein National Research Service Award/Training Grant in Gastrointestinal Allergy and Immunology (T32 AI-07047) (to A.R.–T) and NIH grants DK-57892 and DK-070031 (to J.A.M).

PII: S0016-5085(08)01806-4

doi: 10.1053/j.gastro.2008.10.013

Gastroenterology
Volume 136, Issue 1 , Pages 99-107 , January 2009

Article Tools

* Image Usage & Resolution